跳至主要内容
临床试验/JPRN-UMIN000006995
JPRN-UMIN000006995已完成未知

Basic analysis of new evaluation method in neoadjuvant chemotherapy (Additional study of phase II trial of neoadjuvant chemotherapy for unresectable liver metastasis of colorectal cancer) - CTC in neoadjuvant chemotherapy trial (cTAC trial)

Surgery, Kyorin university hospital0 个研究点目标入组 10 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
10

研究概览

简要总结

This clinical trial was discontinued due to a lack of case accumulation.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with known severe drug hypersensitivity or drug allergies 2) Multiple primaries 3) Metastasis except for liver and regional lymph nodes 4)Infection (fever of 38 degrees C or over) 5) Severe complications (interstitial pneumonia or pulmonary fibrosis, cardiac failure, renal failure, liver failure, uncontrollable diabetes or hypertension, jaundice) 6) Pleural effusion or ascites requiring treatment 7) Diarrhea (water like) 8) During treatment of atazanavir sulfate or flucytosine 9) Pregnant women and women suspected of being pregnant and lactating woman 10) Doctor evaluate inappropriate 11) Thrombosis in arteries or veins

研究者

发起方
Surgery, Kyorin university hospital

相似试验